CORONA REMEDIES LIMITED

08 Dec 2025 - 10 Dec 2025 Individual Category Main Board BSE NSE

Min Investment

₹14868

Price Band

₹1008-₹1062

Issue Size

₹655.00 Cr

Lot Size

14 (per lot)

IPO Dates
img

08 Dec 2025

Open Date

img

10 Dec 2025

Close Date

img

11 Dec 2025

Allotment Date

img

15 Dec 2025

Listing Date

Know Before Investing

Strengths icon

  • Consistent revenue growth with a CAGR of approximately 21% over the last three years.
  • Diversified product portfolio across multiple therapeutic areas.
  • Strong distribution network with a presence in urban and semi-urban areas.
  • Leadership positions in specific therapeutic segments, such as women’s healthcare and pain management.
  • EU-GMP and WHO-certified manufacturing facilities ensure high-quality production standards

Weaknesses icon

  • High working capital intensity with a gross operating cycle exceeding 150 days.
  • Exposure to regulatory risks inherent in the pharmaceutical industry.
  • Dependence on contract manufacturing for certain products.
  • Ongoing capital expenditure projects with associated completion and cost risks.
  • Presence in a competitive and price-controlled domestic pharmaceutical market.

About Corona Remedies Limited

Corona Remedies, founded in 2004 and headquartered in Ahmedabad, Gujarat, is a pharmaceutical company engaged in the research, manufacturing, and marketing of healthcare products. The company offers a range of products across multiple therapeutic areas, including women’s healthcare, cardio-diabetes, pain management, urology, and more. With two manufacturing facilities located in Gujarat and Himachal Pradesh, Corona Remedies has established a significant presence in the Indian pharmaceutical market. The company’s growth strategy includes organic expansion and strategic acquisitions, aiming to enhance its product portfolio and market reach. Corona Remedies continues to focus on delivering quality healthcare solutions to meet the evolving needs of patients. Discuss on Trading Q&A

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 278.52
Non-Institutional Buyers 208.88
Retail Investors 28.73
Total 516.13
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account